Results 151 to 160 of about 46,203 (306)

Incidence, Prevalence, Survival and Mortality of Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma and Waldenström Macroglobulinaemia in Australia. [PDF]

Cancer Med
Nguyen D, Mudiyanselage SB, Talaulikar D, Zhao FL, Tang B, Kamal M, Gao L.   +6 more
europepmc   +1 more source

De-diagnosing chronic lymphocytic leukaemia: An ethical and scientific case for changing diagnostic criteria. [PDF]

Hemasphere
Johnstone P, Allen P, Jimenez-Agrawal P, Agrawal S, Hibbs SP.   +4 more
europepmc   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report. [PDF]

Cureus
Al-Shaker AN, Agarwal A, Saeed MT, Marney Z.   +3 more
europepmc   +1 more source

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. [PDF]

J Clin Med
Robak T, Iskierka-Jażdżewska E, Puła A, Robak P, Puła B.   +4 more
europepmc   +1 more source

An Unusual Presentation of Chronic Lymphocytic Leukaemia [PDF]

Journal of Clinical and Diagnostic Research, 2015
Kavita Paul, Geetika Paul, Harbans Lal Kazal, Nariender Kumar Bairwa   +3 more
doaj   +1 more source

The ethics of a watch-and-wait diagnosis: an exploratory study on the experiences of patients with stage A chronic lymphocytic leukaemia. [PDF]

BMC Med Ethics
Tinland J, Haddadi O, Dann MA.
europepmc   +1 more source

The Global Burden of Leukemia, 1990–2021: A Systematic Analysis of Prevalence, DALYs, and Risk Factors From the Global Burden of Disease Study

Med Research, EarlyView.
Using data from the Global Burden of Disease Study 2021, we systematically assessed leukemia prevalence and disability‐adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021, stratified by subtype, demographics, and risk factors.
Yuping Wu, Haini Zhang, Shuang Luo, Xiangmei Zhang, Mei Tan, Jinmei Chen, Pei Huang, Yan Chen, Zuochen Du   +8 more
wiley   +1 more source

Epidemiology of chronic lymphocytic leukaemia in Germany: A retrospective analysis of administrative claims data. [PDF]

Ann Hematol
Maqhuzu PN, Bocuk D, Boelz S, Hosseini SK, Leeb C, Renevey F, Mevius A, Greth K, Christofyllakis K.   +8 more
europepmc   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

Med Research, EarlyView.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang   +8 more
wiley   +1 more source